MRD’s Potential Role in Treating Acute Myeloid Leukemia
0 Pogledi
• 07/04/23
0
0
Ugraditi
administrator
Pretplatnici
Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari